Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS
NCT02360514
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
226
Enrollment
INDUSTRY
Sponsor class
Conditions
Infection
Interventions
DRUG:
Hantavax injection
Sponsor
Green Cross Corporation